ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA)
$3.92
0.10 (+2.62%)
| CAPS Rating |
|
|---|---|
| Open | $3.85 |
| Previous Close | $3.82 |
| Daily Range | $3.70 - $4.00 |
| 52-Week Range | $1.65 - $6.83 |
| Market Cap | $130.54M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 177,159 |
| Average Daily Volume | 0 |
How do you think ISTA will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
ISTA Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
ISTA News and Commentary
- UPDATE 1-US FDA warns Ista on claims in eye drug promotion – Reuters
- FDA Warns ISTA Pharmaceuticals Over Sales Ad For Xibrom – SmartMoney
- 5-Star Stocks Poised to Pop: ISTA Pharmaceuticals – The Motley Fool
- The Best Investing Ideas in Defensive Stocks – The Motley Fool
- Dream Stocks for Biotech Investors – The Motley Fool
- Build Your Fortune With These Winners – The Motley Fool
- Fearful Stocks for Greedy Investors – The Motley Fool
- THE OLD and the NEW GM and GMGMQ.PK Investors TAKE Note! – Blog at The Motley Fool
- 10 Stocks Shaking the Market – The Motley Fool
- 5 Low-Priced, High-Star Stocks – The Motley Fool
- Do-It-Yourself Retirement: Part 2 – The Motley Fool
Related News and Articles
- Clinical Outcomes? Who Needs 'Em. – The Motley Fool
- FDA Says "No Way!" Market Says "Yeah, Baby!" – The Motley Fool
- Warning: Not All Boxed Warnings Are Equal – The Motley Fool
- A Big Upgrade for Accuray – The Motley Fool
- 5 Stocks That Laugh at Wall Street – The Motley Fool
- Insurers to Washington: We're Not the Problem – The Motley Fool
- Pfizer's 3 Points of Failure – The Motley Fool


RSS Headlines
Fool UK